Eradivir

About Eradivir

Eradivir is a company focused on developing drugs that guide the immune system to fight diseases. Their vision is to harness the power of the immune system through their Bispecific Antigenic immuno-Therapy (BAiT) technology, which uses small molecule immunotherapies to treat and cure diseases such as viral infections and cancer.

Products & Services

EV25:A lead molecule for influenza treatment, shown to be more effective than the current standard of care against all strains of influenza by linking infected cells to antibodies to recruit the immune system for rapid disease clearance.

Bispecific Antigenic immuno-Therapy (BAiT):A small molecule-based technology that tethers a patient's immune cells to diseased cells, facilitating rapid and selective destruction for treating multiple diseases.

Specialties

Immunotherapy Small Molecule Drugs Viral Infection Treatment Cancer Treatment Influenza Treatment

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Private Financing T: - FT: Private Financing	A: 10000000 MR: - FA: $10 million FAN: 10000000	D: 2025-10-07 FD: 2025-10-07	1 investors
2	RT: Series A T: - FT: Series A	A: 10250000 MR: - FA: $10.25 million FAN: 10250000	D: 2024-09-25 FD: 2024-09-25	5 investors

Private Financing Latest

2025-10-07

$10.0M

1 investor (Pro only)

Series A 2024-09-25

$10.2M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

P

Philip S. Low

Chief Scientific Officer

M

Martin Low

Chief Executive Officer

P

Philip Low

Chief Scientific Officer

M

Madduri Srinivasarao

VP of Discovery

J

Jeffery Nielsen

VP of R&D

M

Mary Niedrauer

Director of Drug Development

View 8 more team members with Pro

Unlock Full Team Directory

Recent News

Eradivir Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised